FDA authorizes VitalPatch for monitoring Covid-19 patients—Here's how it works
Share

FDA authorizes VitalPatch for monitoring Covid-19 patients—Here's how it works

CNBC's Tyler Mathisen is joined by Vital Connect CEO Peter Van Haur to talk about how the company's VitalPatch product just got FDA approval to monitor coronavirus patients.
04:08
Fri, May 8 20202:00 PM EDT